Journals / Turkish archives of otorhinolaryngology / 2019 / Cilt: 57 - Sayı: 3

First-Line Molecular Genetic Evaluation of Autosomal Recessive Non-Syndromic Hearing Loss

Pages
140–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, with a detailedgenotype-phenotype association workup, 2 rare casesof Deafness with Palmoplantar Hyperkeratosis andKeratitis-Ichthyosis-Deafness syndrome were reported.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate theefficiency of a first-line molecular genetic evaluationapproach, in children with deafness.Methods: Patients who were found to have sensorineural hearing loss by age-appropriate audiologicaltests were selected for the molecular genetic evaluation.
📊
Key Findings & Data:The molecular genetic evaluation was carriedout with GJB2 gene sequence analysis and mtDNAm.1555A>G mutation Restriction Fragment LengthPolymorphism (RFLP) analysis.
💡
Conclusion & Impact:Furthermore, with a detailedgenotype-phenotype association workup, 2 rare casesof Deafness with Palmoplantar Hyperkeratosis andKeratitis-Ichthyosis-Deafness syndrome were reported.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study is to investigate theefficiency of a first-line molecular genetic evaluationapproach, in children with deafness.Methods: Patients who were found to have sensorineural hearing loss by age-appropriate audiologicaltests were selected for the molecular genetic evaluation. The molecular genetic evaluation was carriedout with GJB2 gene sequence analysis and mtDNAm.1555A>G mutation Restriction Fragment LengthPolymorphism (RFLP) analysis. Additionally, in asmall group of patients, hearing loss Multiplex Ligation-dependent Probe Amplification (MLPA) analysis was done out to identify the possible role of copynumber changes.Results: In this Turkish cohort, which included 104index patients and 78 relatives, 33 (31.7%) had Pathogenic/Likely Pathogenic variants. One or more GJB2sequence variants were identified in 46 (44.1%) of the104 index patients. The homozygous c.35delG mutation by itself explained the etiology in 24% of ourARSNHL group. In one (5%) of the 20 patients ofMLPA group, a hemizygous deletion in POU3F4gene was detected.Conclusion: In our Turkish cohort, we applied afirst-line molecular genetic evaluation approachusing GJB2 gene sequence analysis and mtDNAm.1555A>G RFLP analysis. This approach revealedthe genetic etiology of 44.1% of our index patients.Additionaly, the results of hearing loss MLPA analysis revealed the limited role of copy number changesin this patient group. Furthermore, with a detailedgenotype-phenotype association workup, 2 rare casesof Deafness with Palmoplantar Hyperkeratosis andKeratitis-Ichthyosis-Deafness syndrome were reported.

🔖

Cite This Article

OZYILMAZ, B., MERCAN, G. C., KIRBIYIK, Ö., ÖZDEMİR, T. R., ÖZKARA, S., KAYA, Ö. Ö., KUTBAY, Y. B., ERDOĞAN, K. M., GÜVENÇ, M. S., KOÇ, A. (2019). First-Line Molecular Genetic Evaluation of Autosomal Recessive Non-Syndromic Hearing Loss. Turkish archives of otorhinolaryngology, Cilt: 57 - Sayı: 3, 140–148. https://ajindex.com/articles/368937

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. WHO. Deafness and hearing loss: World Health Organization 2019 [updated 03.2019; cited 2019 08.20.2019]. Available from: URL:
  2. WHO. WHO global estimates on prevalence of hearing loss 2012 [updated 2012; cited 2019 20.08.2019]. Mortality and Burden of Diseases and Prevention of Blindness and Deafness]. Available from:
  3. Paludetti G, Conti G, Di Nardo W, De Corso E, Rolesi R, Picciotti P, et al. Infant hearing loss: from diagnosis to therapy Official Report of XXI Conference of Italian Society of Pediatric Otorhinolaryngology. Acta Otorhinolaryngologica Italica 2012; 32: 347
  4. ASHA. Configuration of Hearing Loss: American Speech-Language-Hearing Association; [cited 2018 01.15.2018]. Available from: URL:
  5. Yan D, Tekin D, Bademci G, Foster J, Cengiz FB, Kannan-Sundhari A, et al. Spectrum of DNA variants for non-syndromic deafness in a large cohort from multiple continents. Human genetics 2016; 135: 953-61. [CrossRef] 6. Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J, Scherer S, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A 2010; 107: 21104-9. [CrossRef] 7. Nonsyndromic hearing loss NIH2019 [updated 01.2019; cited 2019 27.01]. Available from: URL:
  6. Venkatesh M, Moorchung N, Puri B. Genetics of non syndromic hearing loss. Med J Armed Forces India 2015; 71: 363-8. [CrossRef] 9. Wang HL, Chang WT, Li AH, Yeh TH, Wu CY, Chen MS, et al. Functional analysis of connexin‐26 mutants associated with hereditary recessive deafness. J Neurochem 2003; 84: 735-42. [CrossRef] 10. Angeli S, Lin X, Liu XZ. Genetics of hearing and deafness. Anat Rec (Hoboken) 2012; 295: 1812-29. [CrossRef] 11. Liming BJ, Carter J, Cheng A, Choo D, Curotta J, Carvalho D, et al. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol 2016; 90: 251-8. [CrossRef] 12. Tekin M, Duman T, Boğoçlu G, İncesulu A, Çomak E, Ilhan I, et al. Spectrum of GJB2 mutations in Turkey comprises both Caucasian and Oriental variants: roles of parental consanguinity and assortative mating. Hum Mutat 2003; 21: 552-3. [CrossRef] 13. Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipirall